Ken Griffin's position in Gain Therapeutics is currently worth $23.5 Thousand. That's 0.00% of their equity portfolio (4510th largest holding). The first Gain Therapeutics trade was made in Q4 2021. Since then Ken Griffin bought shares five more times and sold shares on three occasions. The stake costed the investor $23.2 Thousand, netting the investor a gain of 1.2% so far.